Alina Beaton, MD
Internal Medicine · Burbank, CANPI 1598953291
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Vertex at 56.1% of the total. 2023 is the largest year on record at $2,484, more than ten times the $133 reported in 2019.
Across 15 payments — averaging $207.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$2K
- Sage Therapeutics, LLC$1K
- Vertiflex, Inc.$114
- Takeda Pharmaceuticals U.S.A., Inc.$18
Across 153 payments — averaging $84,356 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Innocoll Pharmaceuticals Limited$3.8M
- Vertex$2.4M
- Pacira Pharmaceuticals Incorporated$2M
- Pacira Therapeutics, Inc.$1.6M
- Heron Therapeutics, Inc.$1.5M
- Kowa Research Institute, Inc.$1.5M
- plus $232K from 6 others
What the payments were for
- Consulting fees$1,75056%
- Travel & lodging$90929%
- Food & beverage$45815%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 3 | $1,750 |
| Sage Therapeutics, LLC | 8 | $1,234 |
| Vertiflex, Inc. | 3 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$107
How this compares
$3,117 in reported general payments places this provider in the 85th percentile of 13,581 internal medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Burbank
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Hatim HusainSan Diego$2M
- Teck LingPalo Alto$1.1M
- Hyong Kimla Jolla$1M
- Rohit Loombala Jolla$965K
- Fred CohenSan Francisco$929K
- Steven EdelmanSan Diego$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.